2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 129 filers reported holding 2SEVENTY BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $561,062 | +8.2% | 143,128 | +179.4% | 0.00% | – |
Q2 2023 | $518,458 | +142.0% | 51,231 | +124.1% | 0.00% | – |
Q4 2022 | $214,235 | +38.2% | 22,864 | +94.3% | 0.00% | – |
Q2 2022 | $155,000 | -85.5% | 11,765 | -81.2% | 0.00% | – |
Q1 2022 | $1,066,000 | +12.8% | 62,491 | +69.4% | 0.00% | – |
Q4 2021 | $945,000 | – | 36,885 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |